Hightower 6 M Holding, LLC Supernus Pharmaceuticals, Inc. Call Options Transaction History
Hightower 6 M Holding, LLC
- $1.11 Billion
- Q3 2022
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SUPN
# of Institutions
313Shares Held
61.5MCall Options Held
18.4KPut Options Held
0-
Black Rock Inc. New York, NY10.4MShares$512 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.21MShares$305 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY4.81MShares$237 Million2.66% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.02MShares$149 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.76MShares$136 Million0.11% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $2.63B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...